Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-29 @ 12:04 PM
Study NCT ID:
NCT00772733
Status:
COMPLETED
Last Update Posted:
2011-02-23
First Post:
2008-10-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D029424', 'term': 'Pulmonary Disease, Chronic Obstructive'}, {'id': 'D002908', 'term': 'Chronic Disease'}], 'ancestors': [{'id': 'D008173', 'term': 'Lung Diseases, Obstructive'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 936}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2008-10'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-02', 'completionDateStruct': {'date': '2010-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2011-02-21', 'studyFirstSubmitDate': '2008-10-14', 'studyFirstSubmitQcDate': '2008-10-14', 'lastUpdatePostDateStruct': {'date': '2011-02-23', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-10-15', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2010-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Control visits at General practitioners', 'timeFrame': '6-12 months'}, {'measure': 'Lung function measured by spirometry', 'timeFrame': '6-12 months'}], 'secondaryOutcomes': [{'measure': 'Dyspnoea on MRC scale', 'timeFrame': '6-12 months'}, {'measure': 'Smoking status', 'timeFrame': '6-12 months'}, {'measure': 'Rehabilitation completed in the municipality rehabilitation team', 'timeFrame': '6-12 months'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Quality assurance', 'rehabilitation', 'chronic care model', 'COPD'], 'conditions': ['COPD', 'Chronic Diseases']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '35 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Diagnosed patients with COPD, verified by spirometry in general practise and/or municipalities.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* COPD diagnose, verified by spirometry\n* Having given informed consent\n\nExclusion Criteria:\n\n\\-'}, 'identificationModule': {'nctId': 'NCT00772733', 'acronym': 'KOSMOS', 'briefTitle': 'A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment', 'organization': {'class': 'INDUSTRY', 'fullName': 'AstraZeneca'}, 'officialTitle': 'A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment', 'orgStudyIdInfo': {'id': 'NIS-RDK-DUM-2007/1'}}, 'contactsLocationsModule': {'locations': [{'city': 'Aarhus', 'state': 'Arhus', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.15674, 'lon': 10.21076}}, {'city': 'Bjerringbro', 'state': 'Viborg', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.37797, 'lon': 9.66065}}, {'city': 'Møldrup', 'state': 'Viborg', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.77557, 'lon': 9.94418}}, {'city': 'Skals', 'state': 'Viborg', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.55676, 'lon': 9.40381}}, {'city': 'Aalborg', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 57.048, 'lon': 9.9187}}, {'city': 'Klarup', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 57.01194, 'lon': 10.05617}}, {'city': 'Skive', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.56699, 'lon': 9.02707}}, {'city': 'Spøttrup', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 55.93109, 'lon': 10.2379}}, {'city': 'Stoholm', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.48454, 'lon': 9.14617}}, {'city': 'Viborg', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.45319, 'lon': 9.40201}}, {'city': 'Ørum', 'country': 'Denmark', 'facility': 'Research Site', 'geoPoint': {'lat': 56.48072, 'lon': 9.62537}}], 'overallOfficials': [{'name': 'Michael Skov Jensen, MD', 'role': 'STUDY_CHAIR', 'affiliation': 'Region Hospital Viborg, DK'}, {'name': 'Tina Brandt Sorensen, MD', 'role': 'STUDY_CHAIR', 'affiliation': 'Region Hospital Horsens, DK'}, {'name': 'Ove Grann', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Aalborg'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AstraZeneca', 'class': 'INDUSTRY'}, 'responsibleParty': {'oldNameTitle': 'Björn.E.Eriksson, MD, VP Medical', 'oldOrganization': 'AstraZeneca Pharmaceuticals'}}}}